向tsRNA-1797通过调节纯素代谢来缓解糖尿病引起的血管功能障碍
Duo Li1, Jingyue Zhang1, Xiaoyan Han2
1The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China.
Diabetes
|April 24, 2025
概括
一种新的tRNA衍生小RNA,tsRNA-1797,在糖尿病视网膜病变 (DR) 中被上调. 沉默tsRNA-1797通过调节tsRNA-1797-CD73-adenosine通路来改善视网膜血管功能,为DR提供了一个潜在的治疗标.
科学领域:
- 分子生物学分子生物学
- 血管生物学 血管生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 糖尿病视网膜病变 (DR) 是糖尿病的一个显著的微血管并发症,导致视力丧失.
- 在DR中驱动血管功能障碍和代谢障碍的分子机制尚未完全理解.
- 识别新的调节因素对于理解和治疗DR至关重要.
研究的目的:
- 在糖尿病视网膜病变中识别视网膜血管功能障碍的新型分子调节剂.
- 阐明tRNA衍生小RNAs在DR病变发生过程中的作用.
- 调查针对已识别的调节因素的治疗潜力.
主要方法:
- 在糖尿病患者中对tsRNA-1797表达的定量分析.
- 评估内皮质功能障碍的体外研究.
- 在体内实验评估视网膜血管功能的实验.
- 机理学研究调查与纯素代谢和CD73.7的相互作用.
主要成果:
- 在糖尿病患者中,tsRNA-1797的表达显著增加.
- 沉默tsRNA-1797改善内皮功能障碍在体外和视网膜血管功能障碍在体内.
- tsRNA-1797通过通过CD73.7调节腺素的产生来破坏纯素代谢.
- tsRNA-1797-CD73-adenosine轴被确定为DR血管功能障碍的关键调解者.
结论:
- tsRNA-1797是糖尿病视网膜病变中视网膜血管功能障碍的关键调节者.
- 这种tRNA衍生小RNA将代谢失调与DR中的血管并发症联系起来.
- 该tsRNA-1797-CD73-adenosine通路代表了糖尿病血管并发症的有前途的治疗标.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
132
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
132
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K


